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ABSTRACT: Haloalkane dehalogenase (DhlA) catalyzes the hydrolysis of haloalkanes via an alkyl-enzyme
intermediate. Trp175 forms a halogen/halide-binding site in the active-site cavity together with Trp125.
To get more insight in the role of Trp175 in DhlA, we mutated residue 175 and explored the kinetics and
X-ray structure of the Trp175Tyr enzyme. The mutagenesis study indicated that an aromatic residue at
position 175 is important for the catalytic performance of DhlA. Pre-steady-state kinetic analysis of
Trp175Tyr-DhlA showed that the observed 6-fold increase of the Km for 1,2-dibromoethane (DBE) results
from reduced rates of both DBE binding and cleavage of the carbon-bromine bond. Furthermore, the
enzyme isomerization preceding bromide release became 4-fold faster in the mutant enzyme. As a result,
the rate of hydrolysis of the alkyl-enzyme intermediate became the main determinant of the kcat for
DBE, which was 2-fold higher than the wild-type kcat. The X-ray structure of the mutant enzyme at pH
6 showed that the backbone structure of the enzyme remains intact and that the tyrosine side chain lies
in the same plane as Trp175 in the wild-type enzyme. The ClR-stabilizing aromatic rings of Tyr175 and
Trp125 are 0.7 Å further apart and due to the smaller size of the mutated residue, the volume of the
cavity has increased by one-fifth. X-ray structures of mutant and wild-type enzyme at pH 5 demonstrated
that the Tyr175 side chain rotated away upon binding of an acetic acid molecule, leaving one of its
oxygen atoms hydrogen bonded to the indole nitrogen of Trp125 only. These structural changes indicate
a weakened interaction between residue 175 and the halogen atom or halide ion in the active site and help
to explain the kinetic changes induced by the Trp175Tyr mutation.
Haloalkane dehalogenase (DhlA)1 from Xanthobacter
autotrophicus GJ10 hydrolyzes carbon-halogen bonds in a
broad range of haloalkanes, among which are several toxic
xenobiotics (1). This makes it an interesting enzyme from
an environmental point of view. Many details of the catalytic
mechanism and structure of DhlA are now well understood
(2-7). The four-step reaction mechanism (Scheme 1) starts
with the formation of a Michaelis complex, after which the
substrate is covalently bound to the enzyme and a halide
ion is cleaved off. Then the alkyl-enzyme intermediate is
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hydrolyzed to produce an alcohol, which is immediately
released from the enzyme, and in the final step, the halide
ion is removed from the active site. The active site is located
in a cavity that is enclosed by the main domain which has
an R/â-hydrolase fold structure (8, 9), and the cap domain
comprising five R-helices (residues 156-229). The main
domain provides a scaffold for the catalytic triad residues
Asp124, His289, and Asp260, whereas the cap domain
influences the substrate specificity (10) and is proposed to
play a role in halide release (6).
The three-dimensional structures of DhlA with substrate
and with halide product bound showed that Trp175 and
Trp125 form a specific halogen/halide-binding site. The
substrate’s halogen atom, as well as the negatively charged
halide ion, are located in the planes of the aromatic rings,
interacting with the hydrogen atoms of the ring nitrogen
atoms (3, 11). Analysis of several mutants at position 125
or 175 indicated that both residues are involved in transition-
state stabilization during formation of the covalent intermedi-
ate (12). Moreover, Trp175 is located in an N-terminal helix-
loop-helix structure (residues 159-181) in the cap domain
that covers the catalytic site and that was proposed to be
involved in the kinetically observed enzyme isomerization
occurring before the actual halide release (13).
To obtain more insight in the structural and functional role
of Trp175 in haloalkane dehalogenase, we analyzed several
haloalkane dehalogenases with mutations at position 175 and
studied the X-ray structure and steady-state and pre-steady-
state kinetics of the Trp175Tyr enzyme. Trp175 was
substituted by a phenylalanine, tyrosine, histidine, arginine,
and glutamine, the latter of which was made in a previous
study (12). Glutamine and arginine were chosen to check
the importance of an aromatic residue at position 175 for its
interactions with Phe190, Trp194, and the halide ion.
Phenylalanine, tyrosine, and histidine were selected to
investigate the importance of the indole nitrogen, while
retaining aromaticity. The phenylalanine was also picked
because it is located in the modeled structure of the
dehalogenase isolated from Sphingomonas paucimobilis
UT26 at the same position as Trp175 in DhlA (14).
MATERIALS AND METHODS
Materials. Restriction enzymes, Klenow enzyme, T4-
ligase, and isopropyl â-D-thiogalactopyranoside (IPTG) were
obtained from Boehringer Mannheim. Bacteriophage R408,
T7 polymerase, and DNA sequencing reagents were obtained
from Pharmacia LKB Biotechnology. Monodeoxyribo-
nucleoside 5′-triphosphates (dNTPs) were purchased from
Promega, [R-35S]dATP was from Amersham Lifescience, and
the oligonucleotides for site-directed mutagenesis and se-
quencing were synthesized by Eurosequence (Groningen, The
Netherlands). Halogenated compounds were obtained from
Janssen Chimica or from Merck. 2H2O (99.8% v/v) was
purchased from Merck or from Isotec Inc.
Bacterial Strains and Plasmids. Escherichia coli JM101
(Promega) was used for standard DNA manipulations and
the production of single-stranded DNA for sequencing, while
uracil-containing single-stranded DNA for site-directed mu-
tagenesis was produced by E. coli BW313 (15). E. coli strain
BL21(DE3) (16) was used to overproduce mutant haloalkane
dehalogenases.
The mutagenesis and expression vector pGELAF+ was
used to construct the Trp175 mutants of haloalkane dehalo-
genase. This plasmid carries the wild-type dehalogenase
gene (dhlA) under the control of the phage T7 promoter (17).
Site-Directed Mutagenesis. All standard molecular DNA
techniques were performed as described by Sambrook et al.
(18). Mutants of haloalkane dehalogenase were constructed
according to the Kunkel method (15). The general mutagenic
primer used was 5′-GCCTGCAGATGGCTTTACCGCC-
XXXAAATACGAT-3′, in which the introduced PstI restric-
tion site is shown underlined and the codon of amino acid
175 is indicated in boldface type. The codons TAC, TTC,
CAC, and CGC were used to change Trp175 to Tyr, Phe,
His, and Arg, respectively. pGELAF+ was used as a
template, and transformants were screened for an additional
PstI restriction site. DNA sequences were verified by the
dideoxy chain-termination method (19).
Protein Expression and Purification. Expression and
purification of the dehalogenase enzymes involved chroma-
tography on DEAE cellulose and hydroxylapatite as de-
scribed earlier by Schanstra et al. (17). The enzymes were
concentrated with an Amicon ultrafiltration cell using a
PM30 filter and stored at -20 or 4 °C in TEMAG [10 mM
Tris-sulfate, pH 7.5, 1 mM EDTA, 1 mM 2-mercaptoethanol,
3 mM sodium azide, and 10% (v/v) glycerol]. Coomassie
brilliant blue was used to determine protein concentrations
of crude extracts with bovine serum albumin as a standard.
The concentrations of purified enzyme were measured by
its absorbance at 280 nm using the absorbance coefficient
280 ) 4.87  104 M-1cm-1. The purity of the isolated
enzymes was analyzed by SDS-polyacrylamide gel elec-
trophoresis.
Steady-State Kinetics. Dehalogenase assays were carried
out using colorimetric detection of halide release (1). Solvent
kinetic isotope effects were determined by performing
dehalogenase assays in buffers containing 2H2O concentra-
tions ranging 0-90%. The Km, Vmax, and kcat/Km were
calculated from the alcohol and halide production rates at
pH 8.2 and 30 °C, which were measured using colorimetric
assays and gas chromatography, as described previously by
Krooshof et al. (20).
Stopped-Flow Experiments. Stopped-flow fluorescence
quenching experiments were performed to determine the pre-
steady-state kinetics of halide and substrate binding and
steady-state halide dissociation constants (Kd). All measure-
ments were carried out on an Applied Photophysics SX17MV
stopped-flow instrument. The reactions were performed in
TEMAG buffer (pH 8.2) at 30 °C and the reported reactant
concentrations are those in the reaction chamber after mixing.
The excitation wavelength was set at 290 nm, and the
emission was monitored above 320 nm using a cutoff filter.
Each fluorescence trace shown is the average of four
individual experiments.
Rapid-Quench Experiments. Rapid-quench measurements
were performed in TED buffer (50 mM Tris-SO4, pH 8.2, 1
mM EDTA, and 1 mM dithiotreitol) at 30 °C using an RQF-
63 rapid-quench instrument from KinTek Corporation. A
Scheme 1
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reaction was initiated by mixing equal volumes (50 íL) of
protein and substrate, and quenched with 0.3 M H2SO4 (end
concentration) after appropriate time intervals (5 ms to 2 s).
Immediately after quenching, the reaction mixture was
thoroughly extracted with 1.5 mL of ice-cold diethyl ether,
containing 0.05 mM 1-bromohexane as the internal standard.
The diethyl ether phase containing noncovalently bound
substrate and the alcohol produced was neutralized by
addition of H2CO3 and analyzed by gas chromatography as
described for the Km determinations. In all cases, the enzyme
and substrate concentrations cited in the text are those after
mixing and during the enzymatic reaction.
Data Analysis. Apparent steady-state dissociation con-
stants (Kd) for halide binding to DhlA were determined from
the steady-state part of the stopped-flow fluorescence traces.
The calculations involved nonlinear regression fitting
(SigmaPlot, Jandel Scientific) using the equation (F0 - F)/
F0 ) (fa[X-])/([X-] + Kd), where F is the observed
fluorescence at halide concentration [X-], Kd is the apparent
dissociation constant, and fa is the fraction of the total
fluorescence that is quenched at [X-] . Kd.
Nonlinear least-squares analysis of the primary stopped-
flow fluorescence data was performed using the software
provided with the instrument. All fluorescence data obtained
from halide and substrate binding experiments could be
described by the single-exponential equation F ) â + Re-kobst,
in which â is the end level of the fluorescence signal, R is
the amplitude, and kobs is the observed rate. These kinetic
parameters were further used to derive a binding mechanism
with accompanying microscopic rate and equilibrium con-
stants.
Rates and equilibrium constants for substrate conversion
were derived from rapid-quench data by numerical simulation
of Scheme 1, using the computer program Scientist (Micro-
math). The fits were constrained by the experimentally
determined steady-state kcat and Km values and by the fact
that kcat/Km sets the lower limit for k1 (21). The Scientist
output was analyzed with the spreadsheet program Quattro-
Pro (Borland International) to check whether the numerical
simulations agreed with the experimental data. Under initial
velocity steady-state conditions, kcat ) (k2k3kx)/(k2k3 + k2kx
+ k3kx), Km ) [k3kx(k-1 + k2)]/[k1(k2k3 + k2kx + k3kx), and
(kcat/Km) ) (k1k2)/(k-1 + k2). These equations hold for
Scheme 1 and were derived using the determinant method
described by Huang (22).
Crystallization of Trp175Tyr Haloalkane Dehalogenase
and Soaking Experiments. The dehalogenase mutant
Trp175Tyr was subjected to crystallization experiments at
room temperature using the vapor diffusion method in
hanging drop setups. The drops consisted of 4 íL of 5.5
mg/mL protein in 100 mM MES [2-(N-morpholino)ethane-
sulfonic acid] buffer, pH 5.6, mixed with an equal volume
of reservoir solution. Ammonium sulfate was used as a
precipitant in the concentration range 44-58% saturation (at
0 °C) in 100 mM MES buffer (pH 5.6-6.0). Crystals were
obtained within a week from 50% (NH4)2SO4 in 100 mM
MES buffer (pH 5.6). The crystals are lozenge shaped and
belong to the orthorhombic space group P21212, with cell
axes a ) 95.2 Å, b ) 73.0 Å, and c ) 41.5 Å. This is very
similar to the conditions and parameters for the wild-type
crystals (23).
In a soaking experiment, several crystals were immersed
in a solution of 50% (NH4)2SO4 in 100 mM acetate buffer
(pH 5.0) for about 2-3 h at room temperature. Wild-type
DhlA crystals were subjected to the same conditions.
Diffraction Data Collection. Three diffraction experiments
were carried out in total. One data set was collected from
one single crystal of Trp175Tyr-DhlA at pH 6.0 at room
temperature on an Enraf Nonius FAST area detector system
(Enraf Nonius, Delft, The Netherlands). The detector was
equipped with a CAD4 -goniostat and received graphite
monochromatized CuKR radiation (ì ) 1.5418 Å) from an
Elliot GX21 rotating anode X-ray generator. Data were
collected and processed with the MADNES package (24).
Profile fitting and local scaling of the data was done
according to Kabsch (25), after which the data were merged
with the in-house BIOMOL crystallographic package (Protein
Crystallography Group, University of Groningen).
In the same setup, a data set was collected at 120 K from
a mutant enzyme crystal soaked at pH 5.0. A solution of
30% (w/v) PEG 6000, 20% (v/v) glycerol, and 100 mM
acetate buffer (pH 5.0) was applied as a cryoprotectant.
Likewise, a data set was collected at cryo temperature from
a wild-type enzyme crystal soaked in the same pH 5.0 mother
liquor. Further information on the data processing is given
in Table 1.
Structure Solution and Crystallographic Refinement. The
room-temperature structure was solved by positioning the
structure of the wild-type DhlA at pH 6.2 [PDB entry 2HAD
(2)] with Trp175 replaced by Ala as a model in the mutant
cell. Atomic B-factors were taken from the wild-type
structure and kept constant during the refinement because
of the limited resolution. The model was refined with
X-PLOR versions 3.1 and 3.843 (26). A random set of 5%
of the unique reflections was set apart to calculate Rfree values
(27) as an independent validation of the refinement progress.
First, a rigid body refinement was done to position the
molecule more precisely in the asymmetric unit. This led
to a significant drop in Rfree from 30.2 to 25.7% (data from
8 to 4 Å resolution). Then several rounds of positional
refinement were applied using data from 8 to 2.6 Å. An
OMIT Fo - Fc electron density map (28, 29) calculated at
this stage clearly showed density for a tyrosine at the 175
position. This side chain was then extended to tyrosine and
water molecules were included only at positions where the
wild-type DhlA contained solvent molecules as well. This
was followed by several more cycles of positional refinement,
making use of a bulk-solvent mask in X-PLOR (data 20-
2.6 Å). A final cycle of positional refinement including all
data was used to make some final corrections. At all stages,
OMIT 2Fo - Fc and Fo - Fc electron density maps were
calculated and inspected with O (30) to check the agreement
of the model with the data. PROCHECK (31) and
WHATCHECK (32) were used to assess the stereochemical
quality. Whenever necessary the model was manually
adjusted with O. The refinement was stopped when it gave
no further decrease in Rfree or improvement in stereochem-
istry.
The resulting structure was used as a starting model in
the refinement of the pH 5.0 structures of both mutant and
wild-type enzyme. The set of reflections that was set apart
to calculate Rfree values in the room-temperature structure
refinement was extended to cover 5% of the additional
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reflections as well. The models were refined with X-PLOR
version 3.843. The molecule was positioned in the smaller
cell by rigid body refinement and the tryptophan was
reintroduced at the 175 position for the wild-type structure.
This was followed by several cycles of positional and
B-factor refinement, making use of a bulk-solvent mask in
X-PLOR (data beyond 20 Å). In both cases, the refinement
was completed by a cycle including all data. The same
structure validation strategy as described above was applied
throughout the refinement. The atomic coordinates and
structure factor amplitudes for all three structures have been
deposited in the Brookhaven Protein Data Bank with the
entry codes 1bee, 1bez, and 1be0, respectively.
RESULTS
Site-Directed Mutagenesis and Specific ActiVities. Trp175
in haloalkane dehalogenase (DhlA) was mutated to tyrosine,
phenylalanine, histidine, and arginine using the Kunkel
method. The mutated enzymes were all expressed at 17 °C
as soluble protein in quantities similar to wild-type enzyme.
The specific activities of these mutants measured in crude
extracts with 1,2-dichloroethane (DCE) and 1,2-dibromo-
ethane (DBE) are listed in Table 2 and show that DBE
activity increases in the order Arg < Gln < His < Phe <
Tyr  Trp (wild-type residue). Only the tyrosine mutant
displayed no reduction in activity for DBE. DCE could only
be hydrolyzed by the DhlA mutants Trp175Phe and
Trp175Tyr, although 10- and 15-fold slower compared to
the wild-type enzyme, respectively. From these results, it
is obvious that an aromatic residue at position 175 is
important for the catalytic performance of haloalkane dehalo-
genase. The DhlA mutant Trp175Tyr was selected for
further kinetic and structural analysis.
Steady-State Kinetics and Halide Binding of Trp175Tyr
Haloalkane Dehalogenase. Steady-state kinetic parameters
were determined using purified Trp175Tyr-DhlA with DBE
or DCE as the substrates (Table 3). Although this mutant
shows a 2-fold higher conversion rate (kcat) for DBE than
wild-type DhlA, its catalytic efficiency toward this substrate







cell dimensions (Å) a ) 95.2, b ) 73.0, c ) 41.5 a ) 93.1, b ) 72.3, c ) 41.1 a ) 92.6, b ) 72.5, c ) 41.4
resolution range (Å) (highest resolution shell) 32-2.60 (2.67-2.60) 31-2.10 (2.13-2.10) 31-1.96 (2.00-1.96)
no. of observations 13 050 65 239 56 912
no. of unique reflections 7742 13 700 18 082
completeness (%) (highest resolution shell) 82.6 (80.8) 79.0 (60.5) 87.2 (42.3)
〈I/ó(I)〉 8.6 13.6 10.5
Rmerge (%)a (highest resolution shell) 8.1 (27.7) 7.5 (13.6) 7.3 (19.1)
Riso (%)b (highest resolution shell) 14.3 (27.6) 28.2 (39.9) 27.9 (35.0)
Quality of the Final Model
no. of atoms
protein 2476 2476 2478
acetic acid 8 8
solvent 82 279 319
final R-factor (%) 19.3 (20-2.6 Å, all data) 17.1 (20-2.1 Å, all data) 16.9 (20-1.96 Å, all data)
free R-factor (%) 25.3 (20-2.6 Å, test set) 22.5 (20-2.1 Å, test set) 22.0 (20-1.96 Å, test set)
rmsd from ideality
bond lengths (Å) 0.007 0.008 0.008
bond angles (deg) 1.4 1.5 1.5
dihedrals (deg) 23.6 23.4 23.4
impropers (deg) 1.2 1.2 1.2
¢B for bonded atoms 1.4 Å2 1.3 Å2
<B> overall (Å2) 14.1 11.6
<B> protein (Å2) 13.0 10.2
<B> acetic acid active site 29.0 Å2 15.8 Å2
est. coordinate error (Å)c 0.29 0.19 0.17
a Rmerge (%) ) ∑hkl∑refljI(hkl, j) - 〈I(hkl)〉j/∑hkl∑refl〈I(hkl)〉. b Riso (%) ) ∑hkljF(hkl, other) - F(hkl, native)j/∑hklF(hkl, native). c Derived from a óA
plot (43).
Table 2: Specific Activities of Wild-Type and Mutant Haloalkane











a The crude extracts were produced from late-exponential, induced
cultures grown at 17 °C. The expression levels ranged 30-60% of the
total protein contents of cell-free extract. b Substrate solutions contained
5 mM 1,2-dibromoethane (DBE) or 30 mM 1,2-dichloroethane (DCE),
respectively. c (-) not detectable (<25 milliunits/mg).
Table 3: Halide-Binding and Steady-State Activity Parameters of
Purified Wild-Type and Trp175Tyr Haloalkane Dehalogenase for












wild-typeb 0.01 3.0 300 10 0.34 2
Trp175Tyr 0.06 5.0 85 137 0.10 2
1,2-dichloroethane
wild-type 0.53 3.3 6.2 75 0.31 2
Trp175Tyr 2.85 0.33 0.1 >1000 0.10 1
a Solvent (D2O) kinetic isotope effect on dehalogenase activity. kH
and kD are the kcat values determined in H2O and 90% D2O, respectively.
b Taken from Schanstra et al. (7).
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is lower, because of an increase of Km. In the case of DCE,
kcat decreased 10-fold and Km increased 6-fold compared with
wild-type values.
A solvent kinetic isotope effect of 2H2O was observed on
the rate of DBE conversion by Trp175Tyr-DhlA (Table 3),
suggesting that either hydrolysis of the alkyl-enzyme
intermediate (k3 in Scheme 1) or bromide release (kx) is the
rate-determining reaction step (7). The absence of the
isotope effect on the kcat of DCE hydrolysis indicates that in
this case the rate-limiting step has shifted to a step before
hydrolysis of the covalent intermediate.
Besides a reduced affinity for substrate, the Trp175Tyr
mutant also displays a lower affinity for halide ions compared
to wild-type enzyme (Table 3). The apparent dissociation
constant (Kd) increased 14-fold for bromide ions, while the
Kd for chloride ions became too high to be measured
accurately by fluorescence quenching experiments. More-
over, the loss of a tryptophan residue in the mutated enzyme
resulted in a lower degree of quenching (fa) (Table 3).
Pre-Steady-State Kinetic Analysis of 1,2-Dibromoethane
ConVersion by Trp175Tyr-DhlA. A multiple turnover rapid-
quench flow experiment with substrate in 30-fold excess over
enzyme was performed to establish the rate-determining step
in the hydrolysis of DBE by Trp175Tyr-DhlA (Figure 1A).
The Trp175Tyr dehalogenase showed a linear production of
2-bromoethanol in time, whereas a burst of 2-bromoethanol
production was observed with wild-type DhlA (7). The
absence of a product burst implies that 2-bromoethanol
formation or a step preceding it is the slowest reaction step.
Together with the observed kinetic isotope effect we can
conclude that hydrolysis of the intermediate must be the
slowest step in the Trp175Tyr dehalogenase. Furthermore,
Figure 1A clearly indicates that under steady-state conditions
(i.e., in the last part of the curve) the mutant dehalogenase
produced 2-bromoethanol faster than the wild-type enzyme.
The steady-state production rate of 2-bromoethanol was 5.8
s-1 for Trp175Tyr-DhlA, which is similar to the kcat derived
from steady-state halide production (5.0 s-1, Table 3).
A single-turnover rapid-quench experiment in which
enzyme (350 íM) was present in excess over DBE (250 íM)
clearly showed that the substrate was consumed much faster
than 2-bromoethanol was produced or, in other words,
formation of the covalent intermediate was faster than its
hydrolysis, resulting in its accumulation (Figure 1B). This
consolidates the conclusion that hydrolysis of the intermedi-
ate is the rate-limiting step. Furthermore, the higher kcat of
the Trp175Tyr dehalogenase compared to the wild-type
implies that bromide export, which is the slowest step in
wild-type DhlA, became faster in the mutated enzyme.
The rates of the individual reaction steps were determined
by numerical simulation of the 4-step reaction mechanism
in Scheme 1 using the rapid-quench data and the steady-
state parameters kcat and Km (Table 4, fits in Figure 1, panels
A and B). As expected, the slowest step in the conversion
of DBE appeared to be hydrolysis of the covalent intermedi-
ate (k3), although the rate is similar to the wild-type value.
Furthermore, the rate of DBE binding (k1) decreased 6-fold
compared to wild-type DhlA. Formation of the alkyl-
enzyme intermediate (k2) was at least 2-fold slower than with
the wild-type, while the rate of bromide release (kx) was at
least 4-fold higher.
The rate constants derived from single-turnover rapid-
quench experiments could also be used to simulate single-
turnover stopped-flow fluorescence data (Figure 1C). The
relative fluorescence of the Michaelis complex (EâRX),
bromide-bound alkyl-enzyme intermediate (E-RâX-), and
enzyme-bromide complex (EâX-) compared to free enzyme
(E) had to be set at 0.7, 0.75, and 0.9, respectively, compared
to 0.35, 0.55, and 0.66 for the wild-type DhlA. Apparently,
DBE and bromide cause less quenching of the fluorescence
signal of Trp175Tyr-DhlA than of the wild-type signal, which
is in agreement with the loss of a Trp residue that interacts
with substrate.
Bromide Binding to Trp175Tyr-DhlA. Pre-steady-state
kinetics of bromide binding and release were studied by
stopped-flow fluorescence quenching experiments under
FIGURE 1: Pre-steady-state kinetic analysis of 1,2-dibromoethane
(DBE) conversion by Trp175Tyr haloalkane dehalogenase at pH
8.2 and 30 °C. (A) Production of 2-bromoethanol during a multiple-
turnover rapid-quench experiment of 0.35 mM Trp175Tyr-DhlA
(b) or 0.55 mM wild-type DhlA (O) with 10 mM DBE in T50ED
buffer. Wild-type data taken from Schanstra et al. (7). (B) DBE
consumption (O) and 2-bromoethanol production (b) in a single-
turnover rapid-quench experiment of 0.35 mM dehalogenase with
0.25 mM DBE in T50ED buffer. The solid curves are numerical
fits generated by the Scientist program from simulations to Scheme
1. The dotted line represents the simulated concentration of the
alkyl-enzyme intermediate in time. (C) Single-turnover stopped-
flow fluorescence transient obtained after mixing 155 íM enzyme
and 120 íM DBE (end concentrations). The solid line is produced
by simulation of Scheme 1 with the rate and equilibrium constants
mentioned in Table 4 and a fluorescence of 0.7 for the Michaelis
complex, 0.75 for the alkyl-enzyme intermediate, and 0.9 for the
enzyme-bromide complex in relation to free enzyme.
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pseudo-first-order conditions. Figure 2A shows fluorescence
transients obtained after rapid mixing of Trp175Tyr de-
halogenase (7.5 íM) with various concentrations of NaBr
(20-500 mM). Each trace displays an initial burst in
fluorescence decrease up to approximately 50% of the total
quenching. This large initial decrease is complete within 5
ms and is followed by a slower decline of the fluorescence
signal. The fast phases could not be fitted accurately, but
every slow phase fitted an exponential, yielding an apparent
rate (kobs,sl) for each bromide concentration. The kobs,sl
decreased with increasing bromide concentrations (Figure
2B). The simplest reaction mechanism that explains both
the bromide concentration dependence of kobs,sl and the initial
fast fluorescence decrease consists of a rapid bimolecular
step preceded and followed by a slow unimolecular isomer-
ization step (Figure 3, upper route). The E1 species in this
mechanism can bind a bromide ion instantaneously, resulting
in an immediate quenching of the fluorescence signal.
Hence, the initial fluorescence decrease of 50% of the total
quenching, which was not observed with wild-type DhlA,
implies that about 50% of the enzyme molecules are in the
E1 form in the absence of bromide. All individual rate
constants and K5 could be resolved with an accuracy of 10-
20% by numerical simulation and fitting of the fluorescence
traces (Figures 2 and 3). The results show that the
isomerization steps E f E1 and EX f E1X proceed 4-10-
fold faster in the Trp175Tyr mutant than in the wild-type
dehalogenase, whereas the reverse reaction steps were slowed
10-20-fold. Since the forward and reverse reaction steps
have approximately the same rate, about 50% of the
Trp175Tyr-DhlA molecules is in the E1 form in the absence
of halide ions, while that was maximally 1% for the wild-
type dehalogenase. The calculated apparent dissociation
constant (Kd) was in good agreement with the experimentally
determined value (Table 3).
The high Km, high Kd, and low fa of Trp175Tyr-DhlA for
DCE and chloride ions made it impossible to study the pre-
steady-state kinetics of DCE hydrolysis and chloride binding.
X-ray Structure of Trp175Tyr-DhlA at pH 6. To study
the structural details of the effect of the mutation, we
determined the X-ray structure of the Trp175Tyr mutant. The
starting model (wild-type dehalogenase at pH 6.2) had to be
adjusted only slightly in the course of the crystallographic
refinement procedure. In the Trp175Tyr dehalogenase
structure, the tyrosine residue at position 175 could be
modeled nicely into difference Fourier electron density. After
completion of the refinement, the crystallographic R-factor
was 19.3% for all data between 20 and 2.6 Å. The final
model contained one complete molecule of 310 amino acid
residues and 82 water molecules at similar positions as in
the wild-type model. Like in the wild-type structure, the
Ramachandran plot showed two outliers, Asp124 and
Asn148, in generously allowed regions. Some parameters
indicating the good stereochemical quality of the final model
are given in Table 1.
The three-dimensional structure of the mutant enzyme is
very similar to the wild-type structure at pH 6.2 and room
temperature (2). The catalytic triad, formed by residues
Asp124, His289, and Asp260, is intact, although the histidine
side chain has rotated -22° about ł2. The other amino acids
lining the active-site cavity are in an orientation comparable
to that in the wild-type structure. The tyrosine side chain
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et al. (7).
FIGURE 2: Kinetics of bromide binding to Trp175Tyr haloalkane
dehalogenase, analyzed by stopped-flow fluorescence quenching.
(A) Fluorescence transients observed after mixing 7.5 íM enzyme
with 0, 40, 75, 125, and 500 mM NaBr in T50EMAG buffer, pH
8.2, at 30 °C (end concentrations). Each trace displays two distinct
phases of fluorescence decrease; an initial fast phase followed by
a slow phase, the latter of which fitted a single-exponential equation
with an observed rate constant kobs,sl. (B) Observed rate constant
k
obs, sl plotted as a function of the bromide concentration (b). The
solid line is the fit obtained by simulation of a three-step mechanism
as depicted in Figure 3, upper route. (O) wild-type DhlA data taken
from Schanstra and Janssen (6).
FIGURE 3: Kinetic scheme representing bromide binding and release
in wild-type haloalkane dehalogenase (two parallel routes, values
between parentheses), and the DhlA mutant Trp175Tyr (upper route
only, values in boldface type). The fast equilibrium K5 equals k5/
k-5 with k-5 > 30 mM-1 s-1. The Kd can be calculated by Kd )
[K5k4(k6 + k-6)]/[k-6(k4 + k-4)].
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introduced at position 175 lies in the same plane as Trp175
in the wild-type enzyme, with its aromatic ring partially
overlapping the tryptophan pyrrole and phenyl rings (Figure
4A). A short hydrogen bond (2.6 Å) with good geometry is
formed between the tyrosine hydroxyl moiety and the Glu56
main chain carbonyl oxygen. The distance between the
closest atoms of Trp125 and Trp/Tyr175 has increased from
6.6 to 7.3 Å. The cavity volume as calculated with VOIDOO
(33) has somewhat increased from 76 to 93 Å3, mainly as a
result of the smaller size of the tyrosine side chain. Inside
the cavity, only one water molecule can be identified,
whereas there are two present in the wild-type structure. The
nucleophilic water molecule is not clearly discernible either.
The difference is probably due to the lower resolution of
FIGURE 4: Stereoview of the active-site structures of Trp175Tyr and wild-type haloalkane dehalogenase. Relevant residues are drawn as
ball-and-stick and parts of the CR-trace as a coil. All figures are prepared with MOLSCRIPT (44). (A) Superposition of the active site of
Trp175Tyr-DhlA at pH 6 (black lines) and wild-type enzyme at pH 6 (gray lines). Tyr175 in the mutant enzyme is in the same plane as
Trp175 in the wild-type structure. Only one water molecule is found in the mutant active site (Wat1), whereas in the wild-type three water
molecules (Wat1-3) are depicted, with Wat3 being the activated water molecule. (B) Superposition of the active site of Trp175Tyr
dehalogenase at pH 5 (black lines) and at pH 6 (gray lines). At pH 5 an acetic acid molecule is bound in the active site with its carbonyl
oxygen close to Trp125, while Tyr175 has rotated away. (C) Superposition of the active site of wild-type (black lines) and mutant enzyme
(gray lines) at pH 5, both of which are complexed with an acetic acid molecule. Tyr175 in the mutant enzyme is further away from the
acetic acid carbonyl oxygen than Trp175 in wild-type DhlA, because Tyr175 has rotated away in the mutant.
Role of Trp175 in Haloalkane Dehalogenase Biochemistry, Vol. 37, No. 43, 1998 15019
the Trp175Tyr dehalogenase data.
X-ray Structure of Trp175Tyr-DhlA Containing Acetic
Acid at pH 5. The refined structure of the mutant enzyme
at pH 5 is very similar to the mutant structure at pH 6
described above. The rms difference of all CR coordinates
is 0.36 Å (0.32 Å when compared to wild-type, pH 6.2), but
this difference cannot be attributed to a specific region and
is more likely due to the low temperature at which the X-ray
data were collected.
Inside the active-site cavity, an acetic acid molecule from
the cryoprotectant mother liquor is bound (Figure 4B). One
of its oxygen atoms (OXT) lies at the position of a water
molecule in the wild-type and mutant pH 6 structures. It is
hydrogen bonded to the indole nitrogen of Trp125 only. The
other oxygen (O) is at hydrogen-bonding distance from
Asp124Oä1. On the basis of the pKa difference between
acetate and aspartate (4.8 vs 3.9), the acetate is assumed to
be bound in the acid form with the proton on the O atom.
This atom is also within van der Waals contact distance of
the hydroxyl moiety of Tyr175. The acetic acid methyl
group is surrounded by an apolar environment (Phe128 and
Val226). The average B-factor of the molecule is 29.0 Å2,
which is markedly higher than the average B-factor of the
protein atoms within 5 Å distance from the center of the
acetic acid molecule (8.6 Å2). A second acetic acid molecule
is bound at the surface of the protein, close to the N-terminus.
Its hydroxyl oxygen is hydrogen bonded to Asp89Oä1.
As a result of the binding of acetic acid in the active site,
several amino acid side chains have changed position in this
region. The electron density around the Tyr175 side chain
is rather broad in the direction perpendicular to the plane
and allows for a range of orientations, varying ca. 35° in ł2.
The predominant orientation of the tyrosine ring is rotated
35° compared to the structure at pH 6 (Figure 4B). Two
clusters of interacting aromatic residues surrounding the
active-site cavity (Phe222, Trp125, Phe128, Phe164, and
Phe172 and Trp194, Phe190, and Phe290) show a small
concerted movement of their side chains that enables the
Tyr175 side chain to be somewhat flexible. Some of the
residues located close to Tyr175 also show broad electron
density perpendicular to their rings, permitting variations in
ł2. These movements result in a slightly different shape of
the cavity, but the volume is identical to that in the pH 6
structure.
The catalytic triad is intact, and at pH 5, the histidine side
chain displays a similar rotation of -16° about ł2 with
respect to the wild-type structure as in the Trp175Tyr pH 6
structure. The hydrolytic water molecule is now clearly
discernible in the electron density and occupies the same
position close to His289N2 and Glu56O as in the wild-
type structures.
X-ray Structure of Wild-Type DhlA Containing Acetic Acid
at pH 5. For comparison, the wild-type enzyme structure
at pH 5 was determined in a similar soaking experiment.
The overall structure of DhlA at pH 5 is identical to the
mutant structure at this pH and temperature with an rms
difference on all CR coordinates of 0.14 Å. The difference
with the wild-type structure at pH 6.2 and room temperature
is slightly larger, 0.32 Å, although this difference cannot be
ascribed to a defined region of the protein. It is most likely
a general effect of the different temperature. Moreover, the
active-site region closely resembles that of the wild-type
structure at pH 6.2. The amino acid side chains occupy
closely identical positions and the volume of the cavity
amounts to 75 Å3. All residues, including the Trp175, are
well defined in the electron density.
Like in the mutant enzyme at pH 5, an acetic acid molecule
is found inside the cavity in a similar position, but in a
somewhat different orientation (Figure 4C). One of its
oxygen atoms (OXT) has moved toward the center between
the indole nitrogens of Trp125 and Trp175. The other
oxygen atom (O) has shifted over 1.3 Å and is now at
hydrogen-bonding distance from both carboxylic oxygens
of Asp124. Consequently, the methyl group is displaced,
too. The average B-factor of the molecule is 15.8 Å2
compared to an overall B-factor of 4.4 Å2 for all atoms within
5 Å distance. This suggests a better defined, stronger binding
of the acetic acid molecule to the wild-type enzyme than to
the mutant. Another acetate molecule is bound at the surface
of the protein at a position different from that in the mutant
enzyme described above, with one of its oxygen atoms acting
as a hydrogen bond acceptor for Gln10N2 and Arg11NŁ1.
Acetic Acid as a Substrate Analogue. An acetic acid buffer
molecule occupies the active-site cavity in the pH 5 structures
of both wild-type and Trp175Tyr-DhlA. We compared these
two structures with the structure of DhlA noncovalently
complexed with its natural substrate 1,2-dichloroethane [PDB
entry 2DHC (3)]. Both the acetic acid containing mutant
and the wild-type structures are nearly identical to the DCE-
bound structure with rmsd values of 0.31 and 0.32 Å for
CR-atoms, respectively, which could be a simple temperature
effect. Also the residues lining the active-site cavity can be
superimposed on the DCE-bound structure with rmsd values
of 0.40 and 0.39 Å for identical atoms, respectively.
When the three structures are superimposed on the basis
of all CR-atoms, the oxygen atom (OXT) of the acetic acid
molecule in the mutant and wild-type enzyme is close to
the ClR of the DCE molecule at a distance of only 0.7 and
0.6 Å, respectively (Figure 5). The central carbon atom of
the acetic acid in both pH 5 structures is in a similar position
as the C1 carbon atom of DCE, which undergoes the
nucleophilic attack in the second reaction step. The differ-
ence in position is 0.6 and 0.5 Å for the mutant and wild-
type structure, respectively. The methyl group of the acetic
acid molecules is located in the same hydrophobic area of
the cavity as the C2 atom of 1,2-dichloroethane. However,
the acetic acid molecule differs from DCE in that it contains
a protonated oxygen atom that is hydrogen bonded to Asp124
in both wild-type and Trp175Tyr-DhlA, and it obviously
lacks the Clâ atom. Nevertheless, the earlier observations
suggest that acetic acid can be regarded as a substrate
analogue.
Although the binding modes of acetic acid and DCE are
very similar in the wild-type enzyme, the binding environ-
ment of acetic acid is different in the mutant and wild-type
structure. In the wild-type enzyme, the ClR atom of DCE
and the oxygen atom of acetic acid are closer to Trp175 than
to Trp125, whereas in the mutant, this atom has shifted over
1.3 Å and is now stabilized by Trp125 mainly. In addition,
the higher B-factors of the acetic acid molecule and its
surroundings in the mutant enzyme structure suggest that
the binding of substrates is also weaker than that in the wild-
type structure.
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DISCUSSION
Tryptophan 175 forms a halide-binding site in the active
site of DhlA together with Trp125 (3, 11). Upon substrate
entrance in the active-site cavity, these residues bind the
halogen atom between their indole NH groups and they
stabilize the negative charge that develops on the halogen
atom during the cleavage of the carbon-halogen bond (12,
34, 35). Furthermore, Trp175 is part of a helix-loop-helix
structure in the cap domain formed by residues 159-181
that was proposed to be involved in a kinetically observed
enzyme isomerization occurring before the actual halide
release (13).
DhlA mutants with Trp175 replaced by Tyr or Phe retain
significant activity for both 1,2-dibromoethane and 1,2-
dichloroethane, indicating that an aromatic residue at position
175 is important for the catalytic performance of DhlA.
Kennes et al. (12) concluded the same for residue 125. The
preference for aromatic residues at positions 125 and 175
over other halide-stabilizing groups such as guanidinium,
amino, or amide groups can be explained by the fact that
both residues are involved in aromatic interactions with
residues that together form the active site cavity; Trp125
interacts with Phe128 and Phe222, and Trp175 interacts with
Phe190 and Trp194. These interactions will be perturbed
or lost with aliphatic residues such as Arg and Gln at position
175, resulting in a less well stabilized or organized active-
site cavity and halogen/halide-binding site, causing bad
transition-state stabilization, and loss of enzyme activity
despite the presence of functional groups in their side chains
that can interact with the halogen moiety of the substrate.
The structure of the Trp175Tyr dehalogenase mutant at
pH 6 showed that the backbone structure of the enzyme has
remained intact and that the side chain of Tyr175 lies in the
same plane as Trp175 in the wild-type enzyme. Yet, the
Trp175Tyr mutation clearly affects the catalytic properties
of haloalkane dehalogenase. The conversion rate (kcat) for
DBE is 2-fold higher than with the wild-type enzyme and is
mainly determined by the rate of hydrolysis of the alkyl-
enzyme intermediate (k3). This step became the slowest
reaction step because bromide release became faster in the
mutant. Furthermore, the mutant DhlA shows a 6-fold higher
Km for DBE than the wild-type enzyme, which can be
ascribed to reduced rates of both DBE binding (k1) and
carbon-bromine cleavage (k2).
FIGURE 5: Stereoview of the active-site structures of the Trp175Tyr and wild-type DhlA complexed with acetic acid at pH 5 compared to
the structure of DhlA complexed with 1,2-dichloroethane (DCE). Relevant residues are drawn as ball-and-stick and parts of the CR-trace
as a coil. The nucleophilic water molecule (Wat3) is depicted as a small sphere. (A) Superposition of the active site of the Trp175Tyr
mutant-acetic acid complex at pH 5 (black lines) and the wild-type enzyme-DCE complex (gray lines). The acetic acid molecule
superimposes nicely on DCE. Its carbonyl oxygen mimics the ClR of DCE, but only shows close van der Waals interactions to Trp125 as
Tyr175 has rotated away. In the DhlA-DCE complex, the ClR is in the center between the two tryptophan residues. (B) Superposition of
the active site of the wild-type enzyme complexed with acetic acid (black lines) and DCE (gray lines). The acetic acid molecule superimposes
nicely on DCE and its carbonyl oxygen is closer to Trp175 than to Trp125, in contrast to the mutant.
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The lower bimolecular rate constant for DBE binding (k1)
is probably accompanied by a lower binding energy of DBE
that is caused by loss of the interaction between the Trp175
indole NH and the halogen atom. Also the somewhat larger
volume of the cavity and the somewhat wider halogen-
binding site between Tyr175 and Trp125 may affect the
binding energy.
In the second step of the dehalogenation reaction, a
covalent alkyl-enzyme intermediate is formed through a
transition state in which a negative charge develops on the
halogen atom which is then cleaved off (3). This charge is
stabilized by the NH atoms of the indole rings of Trp125
and Trp175 in the wild-type enzyme. The X-ray structure
of the native enzyme with acetic acid bound shows that this
molecule binds in a similar position as the natural substrate
1,2-dichloroethane. Negatively charged groups such as
oxygen or sulfur have been observed to interact with the
positively charged edge of aromatic rings (36-38). There-
fore, we suggest that acetic acid can be regarded as a
substrate analogue. In the Trp175Tyr mutant enzyme, the
acetic acid molecule binds to Trp125 only, suggesting that
transition-state stabilization in the case of DCE or DBE is
achieved predominantly by this residue. This would explain
the decrease in k2 observed in pre-steady-state kinetic
experiments with DBE as the substrate.
The same effects can explain the 6-fold increase of the
Km for DCE. The impact on k2 may be stronger in this case,
since chloride is known to be a worse leaving group than
bromide. The absence of an isotope effect on the kcat of DCE
hydrolysis suggests that k2 has become the slowest reaction
step and may therefore be responsible for the 10-fold
decrease in kcat for DCE compared to the wild-type.
It is likely that the Trp175Phe mutation induces similar
effects as the Trp175Tyr mutation, since a phenylalanine
residue, like tyrosine, is smaller than a tryptophan residue
and lacks the indole nitrogen atom too. A phenylalanine
residue at position 175 would be even more flexible than a
tyrosine, as it would lack the Tyr175OH-Glu56O hydrogen
bond. This could explain the observed lower catalytic
activities of the Trp175Phe dehalogenase compared to the
wild-type activities.
In the third step of the reaction, the covalent alkyl-enzyme
intermediate is hydrolyzed by a water molecule that is
activated by His289. This water molecule is a hydrogen
bond donor to Glu56O, and functions as an acceptor for
Gln123N2 and another water molecule. Although the
activated water molecule is present in the crystal structure
of the mutant at pH 5, it could not be found in the pH 6
structure, most likely because of the medium resolution of
the data. Two components of the hydrolytic machinery show
small changes. First of all, the histidine ring has rotated ca.
-20° about ł2. In this orientation, it makes a somewhat
more favorable interaction with the hydroxyl moiety of
Tyr175, which is positioned in the plane of the histidine ring
at 3.8 Å from the N2 atom. Consequently, the distance
between N2 and the activated water molecule is slightly
increased. Furthermore, Glu56O is within hydrogen-bonding
distance to the hydroxyl group of Tyr175, which might cause
an extra polarization of the CdO bond. However, these are
all only minor differences compared to the wild-type situation
and do not affect the hydrolysis step in the reaction
significantly, as determined by pre-steady-state kinetic
measurement.
To complete the catalytic cycle of DhlA, the halide ion is
released from the cavity. The dissociation constants of
bromide and chloride ions are dramatically affected because
of the weaker interactions with the halide ion and the
increased rotational flexibility of Tyr175 in the mutant
enzyme. The weaker binding of substrate and halide is also
reflected in their reduced ability to quench the fluorescence
of Trp175Tyr dehalogenase.
Halide release is overall four times faster in Trp175Tyr-
DhlA than in the wild-type enzyme. It involves a rapid
bimolecular step preceded and followed by a slow unimo-
lecular isomerization step (Figure 3, upper route), which is
similar to one of the two wild-type export routes (6). The
Trp175Tyr mutant either lacks the alternative way of bromide
release, or k-7 has become slower, making the lower route
invisible in the kinetic studies.
The faster bromide release in the Trp175Tyr dehalogenase
results from accelerated isomerization steps compared to the
wild-type enzyme. The mechanisms associated with the
unimolecular steps may involve conformational changes that
lead to an “open” enzyme from which the halide ion can
readily escape. In the absence of halide ions, less than 1%
of the wild-type DhlA molecules is in the “open” E1 form
(6), whereas this percentage is approximately 50% for
Trp175Tyr-DhlA. This implies that somehow the “open”
enzyme conformations (E1 and E1âX-) are more stabilized
or the “closed” enzyme forms (E and EâX-) are more
destabilized in the mutant enzyme.
Our structural results may provide an explanation for the
kinetically observed “open” and “closed” conformations of
the enzyme. The increased flexibility of Tyr175 and the
occurrence of two main populations of its side chain
conformation suggest that residue 175 is closely involved.
It is conceivable that in the “closed” conformation the
aromatic rings of Trp125 and Trp175 lie in one plane ready
to bind the halogen atom or halide ion, whereas during
isomerization to the “open” form the interaction of the halide
ion with either residue 175 or 125 is lost. A movement of
Tyr175 could be an important step in the slow enzyme
isomerization that was proposed to involve the helix-loop-
helix structure formed by residues 159-181 (13). This
protein region covers the catalytic site and includes residue
175. A weaker interaction between residue 175 or 125 and
the halide ion will increase the rate of the conformational
change, which was indeed found in Trp175Tyr-DhlA.
Additional information about this step could come from, e.g.,
NMR experiments (39, 40), time-resolved fluorescence with
or without Trp-labeling (41), or energy transfer measurements
to map distances between certain residues in the cap and
main domain in the presence and absence of substrate or
halide ions (42).
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